#883: How to Legalize Medical Psychedelics in Your Country — Tania de Jong on The Playbook Behind Australia's World-First Breakthrough

Overview

This episode explores how Tania de Jong and her husband Peter spearheaded the movement that made Australia the first country to legalize MDMA and psilocybin for psychiatric use in 2023. Tania shares the strategies, challenges, and lessons learned from their groundbreaking campaign, offering a playbook for others seeking to drive systemic change in mental health treatment.

Notable Quotes

- If we really believe that something has to be done, then we just have to go for it and we can't let anything stop us. — Tania de Jong, on the persistence required to create change.

- MDMA is very underestimated given how broadly speaking, how manageable it is relative to many of the other psychedelics that we could discuss. — Tim Ferriss, on the potential of MDMA as a therapeutic tool.

- We're all walking each other home. — Ram Dass, as shared by Tania, reflecting the interconnectedness emphasized by psychedelic experiences.

🌱 The Catalyst for Change: A Personal Journey into Psychedelics

- Tania’s journey began in 2015 after reading Tim Ferriss’s blog post about donating to psilocybin research. This inspired her and her husband to explore psychedelics, leading to transformative personal experiences.

- Their first psilocybin session, guided by a Dutch facilitator, was life-changing, fostering a deep sense of connection to themselves, each other, and the world.

- These experiences motivated them to explore how psychedelics could help others, particularly those suffering from mental health challenges like depression and PTSD.

🛠️ Building a Movement: Strategies for Systemic Change

- Tania and Peter founded Mind Medicine Australia in 2019, creating a grassroots movement with over 30 chapters across the country.

- They built a world-class advisory panel, including renowned experts like Rick Doblin, David Nutt, and Gabor Maté, to lend credibility to their cause.

- They launched a robust clinician training program, certifying over 750 professionals in psychedelic-assisted therapy to ensure safe and effective treatment.

- Leveraged cold emails, personal connections, and even Tania’s singing talent to gain access to influential figures and events, including a pivotal conference in the U.S.

📜 Overcoming Regulatory Hurdles

- Mind Medicine Australia submitted multiple applications to the Therapeutic Goods Administration (TGA) to reschedule MDMA and psilocybin from prohibited substances to controlled medicines.

- Despite initial rejections, they persisted, addressing the TGA’s concerns in revised applications and rallying public support. Over 13,000 Australians submitted letters in favor of rescheduling, the largest public response the TGA had ever received.

- A key moment came when Tania brought Professor David Nutt and a widow who shared her husband’s tragic story of untreated depression to present to the TGA, swaying opinions with both scientific evidence and emotional impact.

🌍 Scaling Access and Building Infrastructure

- Following the rescheduling, over 20 clinics across Australia began offering MDMA and psilocybin-assisted therapy, with more than 400 patients treated so far.

- Mind Medicine Australia is addressing barriers like high treatment costs (up to $15,000 USD for a full course) by establishing a patient support fund and securing funding from insurers and government agencies like Medibank and the Department of Veterans Affairs.

- They are also collecting real-world evidence through a registry at the Australian National University to demonstrate the efficacy and safety of these treatments, with remission rates of 60-80% for conditions like PTSD and depression.

🎤 Lessons in Advocacy: Persistence, Partnerships, and Personal Stories

- Tania emphasized the importance of persistence, even in the face of resistance from researchers, regulators, and skeptics.

- Building alliances with influential figures and organizations was crucial. For example, David Nutt’s presentations and the emotional testimony of a widow were instrumental in swaying regulators.

- Mistakes included underestimating resistance from vested interests in the research community and hiring individuals who were not yet ready for the high-pressure environment of advocacy work.

- Tania advises advocates to focus on data, science, and storytelling while being mindful of not pushing too hard, as it can backfire.

💡 The Future of Psychedelic-Assisted Therapy

- Tania predicts exponential growth in the number of trained clinicians, authorized prescribers, and treated patients in Australia over the next few years.

- She highlights the potential of group therapy and shorter-acting compounds like methylene to reduce costs and increase accessibility.

- Mind Medicine Australia continues to push for expanded access, including the use of psilocybin for end-of-life anxiety, and is raising funds to support patients who cannot afford